Financial analytics technology tackles ‘Big Data’ crop research
15 August 2016
The Earlham Institute (EI) has selected Kx Systems (Kx) as their technology partner for a new project which will revolutionise research into bioinformatics and promote a sustainable bioeconomy.
Dr Ji Zhou, Project Leader, and his colleagues at EI are planning to develop and embed the latest machine-learning algorithms, including deep learning techniques in
For more than 20 years, Kx has been the powerhouse in high-speed, big data analytics in the world’s major financial centres. This expertise will now be used by EI in a completely new approach to the analytical processing of living systems. In an environment where the need to process increasing volumes of data at ever-greater speeds has been failed by the traditional query-response model, Kx will provide real-time active queries for the enormous datasets generated in life sciences.
Dr Tim Stitt, Head of Scientific Computing at EI, commented: “For EI to remain at the forefront of bioscience research it is imperative that we continue to partner with the world’s leading technology providers. I’m therefore delighted to collaborate with Kx, as we continue to explore new technologies for addressing the challenges of ever-increasing data volumes. Leveraging the high-performance data processing capabilities of
To address the challenges presented by the emergence of Big Data in
The UK government has recently reinforced its strategy in agriculture with IoT (Internet of Things) technologies to help maximise yields, improve food traceability, and tackle environmental challenges through networked remote sensors, particularly for crop development and genetic research. This policy change, combined with EI’s long-term strategy of agri-tech and high-performance computing (HPC), demonstrates a valuable opportunity to apply the real-time analytical technology to research genotype-phenotype-environment interactions based on EI’s world-leading HPC infrastructure.
EI is strategically funded by BBSRC and operates a National Capability to promote the application of genomics and bioinformatics to advance bioscience research and innovation.
Notes to editors
For more information, please contact:
Marketing & Communications Officer, Earlham Institute (EI)
- +44 (0)1603 450 107
The Earlham Institute (EI) is a world-leading research institute focusing on the development of genomics and computational biology. EI is based within the Norwich Research Park and is one of eight institutes that receive strategic funding from Biotechnology and Biological Science Research Council (BBSRC) - £6.45M in 2015/2016 - as well as support from other research funders. EI operates a National Capability to promote the application of genomics and bioinformatics to advance bioscience research and innovation.
EI offers a state of the art DNA sequencing facility, unique by its operation of multiple complementary technologies for data generation. The Institute is a UK hub for innovative bioinformatics through research, analysis and interpretation of multiple, complex data sets. It hosts one of the largest computing hardware facilities dedicated to life science research in Europe. It is also actively involved in developing novel platforms to provide access to computational tools and processing capacity for multiple academic and industrial users and promoting applications of computational Bioscience. Additionally, the Institute offers a training programme through courses and workshops, and an outreach programme targeting key stakeholders, and wider public audiences through dialogue and science communication activities.
Kx is the world leader in high-performance, in-memory computing, streaming analytics and operational intelligence. For more than 20 years the world's largest banks, brokers and regulators have been relying on Kx technology to address the challenges posed by exploding volumes of data, regulatory requirements and the need for ever-faster processing.
With more than 100 major global corporations as clients, Kx works closely with its user group to drive and prioritize its research and development so that it delivers the most innovative software, tools, solutions and services to solve its customers’ business needs. As the Internet of Things creates never before seen volumes of structured machine data, new industries are embracing Kx technology's proven ability to store and analyze data in real-time.
In the pharmaceutical and life sciences sectors, Kx is helping organizations realize the value that can be derived from their datasets in all areas of their business from research and development to production, sales, and increasingly regulatory reporting.
Kx is a division of First Derivatives plc. (FD). FD is quoted on the London Stock Exchange (FDP:LN) and is a global supplier of software and consulting services. FD has had double-digit revenue growth every year since it was incorporated in 1996.
For more information about Kx please visit www.kx.com. For general inquiries, write to email@example.com.
The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by Government, BBSRC invested over £509M in world-class bioscience in 2014-15 and is the leading funder of wheat research in the UK (over £100M investment on UK wheat research in the last 10 years). We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
Our mission is to generate knowledge of plants and microbes through innovative research, to train scientists for the future, to apply our knowledge of nature’s diversity to benefit agriculture, the environment, human health and wellbeing, and engage with policy makers and the public.
To achieve these goals we establish pioneering long-term research objectives in plant and microbial science, with a focus on genetics. These objectives include promoting the translation of research through partnerships to develop improved crops and to make new products from microbes and plants for human health and other applications. We also create new approaches, technologies and resources that enable research advances and help industry to make new products. The knowledge, resources and trained researchers we generate help global societies address important challenges including providing sufficient and affordable food, making new products for human health and industrial applications, and developing sustainable bio-based manufacturing.
This provides a fertile environment for training the next generation of plant and microbial scientists, many of whom go on to careers in industry and academia, around the world.
The John Innes Centre is strategically funded by the Biotechnology and Biological Sciences Research Council (BBSRC). In 2014-2015 the John Innes Centre received a total of £36.9 million from the BBSRC.